Stock listing
EPRX Stock Price, News, Filings & Events — Eupraxia Pharmaceuticals, Inc.
Selected listing: EPRX · NASDAQ · USD · US
This page tracks Eupraxia Pharmaceuticals, Inc.'s EPRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EPRX:NASDAQ. EPRX:NASDAQ is the stock-level entry point for investors researching Eupraxia Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- EPRX:NASDAQ
- Asset type
- Stock
- Market cap
- $483.5M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Eupraxia Pharmaceuticals, Inc. EPRX:NASDAQ stock context
This page tracks Eupraxia Pharmaceuticals, Inc.'s EPRX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following EPRX:NASDAQ. EPRX:NASDAQ is the stock-level entry point for investors researching Eupraxia Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals Reports Symptom Response Data from its Ongoing Phase 1b/2a RESOLVE Trial, Including New Data on Odynophagia (Pai...
August 13, 2026
Eupraxia Pharmaceuticals Reports Second Quarter 2026 Financial Results 
August 11, 2026
Eupraxia Pharmaceuticals Strengthens Executive Leadership Team to Support Next Phase of Growth
July 13, 2026
Eupraxia Pharmaceuticals Strengthens Board with Three Industry Leaders in Drug Development and Commercialization
July 7, 2026
Eupraxia Pharmaceuticals Announces Voting Results from Annual General Meeting of Shareholders
June 19, 2026
Research Eupraxia Pharmaceuticals, Inc.
Eupraxia Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for EPRX:NASDAQ.
Eupraxia Pharmaceuticals, Inc. company profile
View the public company page for Eupraxia Pharmaceuticals, Inc. on 6ix.
Eupraxia Pharmaceuticals, Inc. news
Read company news and market updates connected to Eupraxia Pharmaceuticals, Inc..
Eupraxia Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Eupraxia Pharmaceuticals, Inc..
Alternate listings
EPRX:TSX
CA · CAD
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.
EPRX:NEO
CA · CAD
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.
A3EGRS:LS
DE · EUR
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.
A3EGRS:LSX
DE · EUR
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.
EPRX:BOATS
US · USD
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.
X43:FWB
DE · EUR
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.
X43:SWB
DE · EUR
Alternate listing for Eupraxia Pharmaceuticals, Inc.; the primary context on this page is EPRX:NASDAQ.